中华物理医学与康复杂志
中華物理醫學與康複雜誌
중화물리의학여강복잡지
CHINESE JOURNAL OF PHYSICAL MEDICINE AND REHABILITATION
2014年
12期
939-941
,共3页
贾红娥%许涛%郭铁成%王熠钊
賈紅娥%許濤%郭鐵成%王熠釗
가홍아%허도%곽철성%왕습쇠
脑卒中%肩-手综合征%局部振动疗法
腦卒中%肩-手綜閤徵%跼部振動療法
뇌졸중%견-수종합정%국부진동요법
Shoulder-hand syndrome%Stroke%Focal vibration
目的 观察局部振动疗法治疗肩-手综合征(SHS)的疗效.方法 共观察了2例脑卒中后并发SHS患者,初期采用针灸、推拿、关节松动和关节活动度(ROM)训练、气压治疗、中药热敷、冷-热浴交替治疗等常规康复治疗4周后,症状改善不明显.随后加用局部振动治疗2周,治疗前后采用SHS评分标准进行评定.结果 经加用局部振动治疗后患者患侧上肢疼痛缓解,水肿、痉挛减轻,关节活动度增加,2例患者的SHS评分均从局部振动治疗前的12分下降至治疗后的5分.同时患肢功能亦有一定恢复.结论 局部振动疗法能有效缓解SHS症状,可作为脑卒中后SHS治疗的一项新的干预措施.
目的 觀察跼部振動療法治療肩-手綜閤徵(SHS)的療效.方法 共觀察瞭2例腦卒中後併髮SHS患者,初期採用針灸、推拿、關節鬆動和關節活動度(ROM)訓練、氣壓治療、中藥熱敷、冷-熱浴交替治療等常規康複治療4週後,癥狀改善不明顯.隨後加用跼部振動治療2週,治療前後採用SHS評分標準進行評定.結果 經加用跼部振動治療後患者患側上肢疼痛緩解,水腫、痙攣減輕,關節活動度增加,2例患者的SHS評分均從跼部振動治療前的12分下降至治療後的5分.同時患肢功能亦有一定恢複.結論 跼部振動療法能有效緩解SHS癥狀,可作為腦卒中後SHS治療的一項新的榦預措施.
목적 관찰국부진동요법치료견-수종합정(SHS)적료효.방법 공관찰료2례뇌졸중후병발SHS환자,초기채용침구、추나、관절송동화관절활동도(ROM)훈련、기압치료、중약열부、랭-열욕교체치료등상규강복치료4주후,증상개선불명현.수후가용국부진동치료2주,치료전후채용SHS평분표준진행평정.결과 경가용국부진동치료후환자환측상지동통완해,수종、경련감경,관절활동도증가,2례환자적SHS평분균종국부진동치료전적12분하강지치료후적5분.동시환지공능역유일정회복.결론 국부진동요법능유효완해SHS증상,가작위뇌졸중후SHS치료적일항신적간예조시.
Objective To observe the therapeutic efficacy of focal vibration on shoulder-hand syndrome (SHS) in stroke patients.Methods Two stroke patients with SHS were observed.Both patients were treated with routine interventions including exercises,manipulation,intermittent sequential pneumatic compression,medications etc at the beginning,but got no significant improvement after 4 weeks of treatment.Focal vibration was then added on by applying it on the affected side for 10-12 minutes,once daily for 2 weeks.The SHS scoring system developed by Braus and colleagues was used to evaluate the outcome.Results It was found that after 2 weeks of treatment with focal vibration,both patients were improved significantly,in terms of pain,edema and shoulder range of movement,as reflected by the changes of SHS scores.The SHS scores of both patients were 12 before treatment with focal vibration and reduced to 5 after the treatment.Conclusions Focal vibration could be an effective option for the management of SHS in stroke patients.